{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:35:38Z","timestamp":1790688938781,"version":"4.1.0"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"6","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergies and Infectious Diseases","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH"},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH"},{"name":"Department of Health and Human Services","award":["HHSN272200800014C"],"award-info":[{"award-number":["HHSN272200800014C"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Infect Dis."],"published-print":{"date-parts":[[2016,3,15]]},"DOI":"10.1093\/cid\/civ991","type":"journal-article","created":{"date-parts":[[2015,12,10]],"date-time":"2015-12-10T04:05:08Z","timestamp":1449720308000},"page":"761-769","source":"Crossref","is-referenced-by-count":53,"title":["Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel"],"prefix":"10.1093","volume":"62","author":[{"given":"Amita","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti S.","family":"Mathad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Abdel-Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica D.","family":"Albano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Botgros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikki","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee S.","family":"Browning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E.","family":"Dooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devasena","family":"Gnanashanmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Grinsztejn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Hernandez-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Jean-Philippe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne D.","family":"Lyerly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mirochnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne M.","family":"Mofenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Montepiedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanna","family":"Piper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radojka","family":"Savic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Heather","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,12,9]]},"reference":[{"key":"2016030108084831000_62.6.761.1","unstructured":"World Health Organization. Global tuberculosis report 2015. Available at: http:\/\/www.who.int\/tb\/publications\/global_report\/en\/ . Accessed 2 December 2015."},{"key":"2016030108084831000_62.6.761.2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(14)70330-4"},{"key":"2016030108084831000_62.6.761.3","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(14)70338-9"},{"key":"2016030108084831000_62.6.761.4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis732"},{"key":"2016030108084831000_62.6.761.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2009.12.005"},{"key":"2016030108084831000_62.6.761.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(04)00939-9"},{"key":"2016030108084831000_62.6.761.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2012.01856.x"},{"key":"2016030108084831000_62.6.761.8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068733"},{"key":"2016030108084831000_62.6.761.9","first-page":"675","article-title":"A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death","volume":"3","author":"Ahmed","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"2016030108084831000_62.6.761.10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201106-1083OC"},{"key":"2016030108084831000_62.6.761.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1405047"},{"key":"2016030108084831000_62.6.761.12","doi-asserted-by":"publisher","DOI":"10.1053\/sper.2001.24565"},{"key":"2016030108084831000_62.6.761.13","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544100-00001"},{"key":"2016030108084831000_62.6.761.14","unstructured":"Food and Drug Administration. Pregnancy and lactation labeling final rule. Available at: http:\/\/1.usa.gov\/1CpyUFt . Accessed 10 April 2015."},{"key":"2016030108084831000_62.6.761.15","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90309-L"},{"key":"2016030108084831000_62.6.761.16","unstructured":"European Medicine Agency. European Medicines Agency recommends two new treatment options for tuberculosis. 2013. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2013\/11\/WC500155472.pdf . Accessed 24 November 2013."},{"key":"2016030108084831000_62.6.761.17","unstructured":"Food and Drug Administration. Guidance for industry: establishing pregnancy exposure registries. 2002. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm071639.pdf . Accessed 13 March 2014."},{"key":"2016030108084831000_62.6.761.18","unstructured":"World Health Organization. Treatment of tuberculosis: guidelines. Geneva, Switzerland: World Health Organization; 2010."},{"issue":"RR-11","key":"2016030108084831000_62.6.761.19","first-page":"1","article-title":"Treatment of tuberculosis","volume":"52","author":"Centers for Disease Control and Prevention","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"2016030108084831000_62.6.761.20","first-page":"147","article-title":"Should pyrazinamide be preferred in tuberculosis treatment during pregnancy?","volume":"138","author":"Karabay","year":"2013","journal-title":"Indian J Med Res"},{"key":"2016030108084831000_62.6.761.21","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200109280-00016"},{"key":"2016030108084831000_62.6.761.22","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/379271"},{"key":"2016030108084831000_62.6.761.23","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328359590f"},{"key":"2016030108084831000_62.6.761.24","doi-asserted-by":"crossref","first-page":"796590","DOI":"10.1155\/2012\/796590","article-title":"Adherence with drug therapy in pregnancy","volume":"2012","author":"Matsui","year":"2012","journal-title":"Obstet Gynecol Int"},{"key":"2016030108084831000_62.6.761.25","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu429"},{"key":"2016030108084831000_62.6.761.26","unstructured":"Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. 2014. Available at: http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/perinatalgl.pdf . Accessed 10 July 2014."},{"key":"2016030108084831000_62.6.761.27","unstructured":"World Health Organization Stop TB Partnership. The global plan to stop TB 2011\u20132015. Transforming the fight: towards elimination of tuberculosis. Available at: http:\/\/www.stoptb.org\/assets\/documents\/global\/plan\/tb_globalplantostoptb2011-2015.pdf . Accessed 15 March 2015."},{"key":"2016030108084831000_62.6.761.28","unstructured":"World Health Organization. Recommendation on 36 months isoniazid preventive therapy to adults and adolescents living with HIV in resource-constrained and high TB- and HIV-prevalence settings: 2015 update. Available at: http:\/\/www.who.int\/tb\/publications\/2015_ipt_update\/en\/ . Accessed 15 March 2015."},{"key":"2016030108084831000_62.6.761.29","doi-asserted-by":"crossref","unstructured":"Taylor AW , Mosimaneotsile B , Mathebula U et al . Pregnancy outcomes in HIV-infected women receiving long-term isoniazid prophylaxis for tuberculosis and antiretroviral therapy. Infect Dis Obstet Gynecol 2013; doi:10.1155\/2013\/195637 .","DOI":"10.1155\/2013\/195637"},{"key":"2016030108084831000_62.6.761.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104875"},{"key":"2016030108084831000_62.6.761.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005136"},{"key":"2016030108084831000_62.6.761.32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092308"},{"key":"2016030108084831000_62.6.761.33","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000209"},{"key":"2016030108084831000_62.6.761.34","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.13.0624"},{"key":"2016030108084831000_62.6.761.35","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.12.0068"},{"key":"2016030108084831000_62.6.761.36","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-014-0204-8"},{"key":"2016030108084831000_62.6.761.37","unstructured":"Food and Drug Administration. Guidance for industry. Pharmacokinetics in pregnancy\u2014 study design, data analysis, and impact on dosing and labeling. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/...\/Guidances\/ucm072133.pdf. Accessed 12 March 2014."},{"key":"2016030108084831000_62.6.761.38","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00007-9"},{"key":"2016030108084831000_62.6.761.39","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH harmonised tripartite guideline. Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals M3(R2). 2009. Available at: http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Multidisciplinary\/M3_R2\/Step4\/M3_R2__Guideline.pdf . Accessed 13 March 2014."},{"key":"2016030108084831000_62.6.761.40","unstructured":"International Conference on Harmonisation . Detection of toxicity to reproduction for medicinal products & toxicity to male fertility S5(R2). 2005. Available at: http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Safety\/S5\/Step4\/S5_R2__Guideline.pdf. Accessed 13 March 2014."},{"key":"2016030108084831000_62.6.761.41","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH harmonised tripartite guideline. Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use S2(R1). 2011. Available at: http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Safety\/S2_R1\/Step4\/S2R1_Step4.pdf. Accessed 13 March 2014."},{"key":"2016030108084831000_62.6.761.42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/15265161.2011.562595","article-title":"An ethically justified framework for clinical investigation to benefit pregnant and fetal patients","volume":"11","author":"Chervenak","year":"2011","journal-title":"Am J Bioeth"},{"key":"2016030108084831000_62.6.761.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.whi.2012.10.003"},{"key":"2016030108084831000_62.6.761.44","unstructured":"Code of Federal Regulation, Title 45 Public Welfare, Department of Health and Human Services, part 46, Protection of Human Subjects, Subpart B \u2013 Additional Protections for Pregnant Women, Human fetuses and Neonates Involved in Research [volume No 66] Federal Register [Page 56779] (2001) (45 CFR 46, section \u00a7 46.204). Available at: http:\/\/www.hhs.gov\/ohrp\/humansubjects\/guidance\/45cfr46.html. Accessed 1 December 2015."},{"key":"2016030108084831000_62.6.761.45","doi-asserted-by":"publisher","DOI":"10.1353\/hcr.0.0211"},{"key":"2016030108084831000_62.6.761.46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/15265161.2011.560353","article-title":"Reframing the framework: toward fair inclusion of pregnant women as participants in research","volume":"11","author":"Lyerly","year":"2011","journal-title":"Am J Bioeth"},{"key":"2016030108084831000_62.6.761.47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-720X.1996.tb01831.x"},{"key":"2016030108084831000_62.6.761.48","doi-asserted-by":"crossref","unstructured":"Lyerly AD , Little MO , Faden RR . Pregnancy and clinical research. Hastings Cent Rep 2008; 38:inside back cover.","DOI":"10.1353\/hcr.0.0089"},{"key":"2016030108084831000_62.6.761.49","unstructured":"Food and Drug Administration. Guidance for industry. Pulmonary tuberculosis: developing drugs for treatment. Available at: http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm373580.pdf . Accessed 3 March 2015."},{"key":"2016030108084831000_62.6.761.50","unstructured":"Food and Drug Administration. Guidance for industry. Pharmacokinetics in pregnancy\u2014study design, data analysis, and impact on dosing and labelling. 2004. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/\u2026\/Guidances\/ucm072133.pdf . Accessed 12 March 2014."},{"key":"2016030108084831000_62.6.761.51","unstructured":"Guideline for the Study and Evaluation of Gender Differences in the Clinical Evaluation of Drugs:III. Revised policy on inclusion of women of childbearing potential in Clinical Trials. Federal Register 1993; 58(139):39407. Available at: http:\/\/www.fda.gov\/downloads\/RegulatoryInformation\/Guidances\/UCM126835.pdf. Accessed 11 December 2015."},{"key":"2016030108084831000_62.6.761.52","unstructured":"European Medicines Agency. Committee for Medicinal Products for Human Use. Guideline on risk assessment of medicinal products on human reproduction and lactation: from data to labelling. 2008. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003307.pdf . Accessed 12 March 2014."},{"key":"2016030108084831000_62.6.761.53","doi-asserted-by":"publisher","DOI":"10.1053\/sper.2001.24905"},{"key":"2016030108084831000_62.6.761.54","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-011613-140009"},{"key":"2016030108084831000_62.6.761.55","unstructured":"Food and Drug Administration. Reviewer guidance: evaluating the risks of drug exposure in human pregnancies. 2005. Available at: http:\/\/www.fda.gov\/downloads\/scienceresearch\/specialtopics\/womenshealthresearch\/ucm133359.pdf . Accessed 13 March 2014."},{"key":"2016030108084831000_62.6.761.56","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu709"},{"key":"2016030108084831000_62.6.761.57","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu600"},{"key":"2016030108084831000_62.6.761.58","unstructured":"FDA. Guidance for industry. Exposure-response relationships\u2014study design, drug analysis, and regulatory applications. 2003. Available at: http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm064982.htm . Accessed 29 October."},{"key":"2016030108084831000_62.6.761.59","unstructured":"Brown V , Albano J , Phelps K , Whitehouse J . Use of pregnancy registries for risk management. In: Sietsema WK , Sprafka JM , eds. Risk management principles for devices and pharmaceuticals: global perspectives on the benefit: risk assessment of medicinal products. 1st ed. Rockville, MD: Regulatory Affairs Professional Society, 2012:95\u2013100."},{"key":"2016030108084831000_62.6.761.60","unstructured":"European Medicines Agency. Committee for Medicinal Products for Human Use. Guideline on the exposure to medicinal products during pregnancy: need for post-authorisation data. 2005. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Regulatory_and_procedural_guideline\/2009\/11\/WC500011303.pdf . Accessed 13 March 2014."},{"key":"2016030108084831000_62.6.761.61","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907736"},{"key":"2016030108084831000_62.6.761.62","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0911486"},{"key":"2016030108084831000_62.6.761.63","unstructured":"International Maternal Pediatric Adolescent AIDS Clinical Trials Network. Studies. Available at: http:\/\/impaactnetwork.org\/studies\/index.asp#devel . Accessed 1 December 2015."}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/62\/6\/761\/16789191\/civ991.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T05:43:47Z","timestamp":1589607827000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/civ991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,9]]},"references-count":63,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,3,1]]},"published-print":{"date-parts":[[2016,3,15]]}},"alternative-id":["10.1093\/cid\/civ991"],"URL":"https:\/\/doi.org\/10.1093\/cid\/civ991","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,9]]}}}